Keyphrases
Ivermectin
100%
Onchocerciasis
85%
Tolerability
80%
Eyelid
46%
Microfilaria
42%
Ghana
42%
Cataract Extraction
40%
Complicated Cataract
40%
Corneal Endothelial Transplantation
40%
Ocular Infection
40%
Conjunctival Intraepithelial Neoplasia
40%
Posterior Capsular Rupture
40%
High-risk Human Papillomavirus (HR-HPV)
40%
One Dose
40%
Young Patients
40%
Basal Cell Carcinoma
40%
Daily Dose
40%
Ocular Burns
40%
Conjunctival
40%
Electronic Cigarettes
40%
Onchocerca Volvulus
40%
Laceration
40%
Albendazole
40%
Pathologic
40%
Besifloxacin
40%
Bulbar
40%
Ocular Surface Infections
40%
Diethylcarbamazine
40%
Corneoscleral
40%
Myeloid Sarcoma
40%
Intraoperative Management
40%
Acute Myeloid Leukemia
40%
Mycobacterium Chelonae
40%
Ocular Trauma
30%
Corneal Burn
30%
Cataract Surgery
30%
Mass Drug Administration
20%
Blindness
20%
BerEP4
20%
Management Strategy
20%
Keratitis
20%
Worm
16%
Amikacin
15%
Conjunctivitis
15%
Excisional Biopsy
13%
Tumor
13%
Caruncle
13%
Risk Factors
13%
Immunostaining
13%
Eyelid Mass
13%
Medicine and Dentistry
Ivermectin
100%
Onchocerciasis
91%
Cataract Surgery
70%
Infection
47%
Eyelid
45%
Basal-Cell Carcinoma
40%
Eye Infection
40%
Onchocerca volvulus
40%
Single Drug Dose
40%
Albendazole
40%
Diethylcarbamazine
40%
Intraepithelial Neoplasia
40%
Lens Capsule Rupture
40%
Myeloid Sarcoma
40%
Acute Myeloid Leukemia
40%
Laceration
40%
Wart Virus
40%
Electronic Cigarette
40%
Besifloxacin
40%
Mycobacterium chelonae
40%
Ocular Surface
40%
Eye Injury
30%
Cornea Burn
30%
Vitreous
30%
Biopsy Technique
25%
Drug Administration
20%
Surgeon
20%
Keratitis
17%
Immunohistochemistry
17%
Anterior Chamber of Eyeball
15%
Adverse Event
15%
Eyelid Disease
13%
Upper Eyelid
13%
Leukemia
13%
Eyelid Tumor
13%
Orbital Inflammation
13%
Amikacin
13%
Conjunctivitis
13%
Neoplasm
11%
Recurrent Disease
10%
Disease
10%
Parasitic Disease
10%
Infection Rate
10%
Visual Impairment
10%
Globe Rupture
10%
Visual Acuity
10%
Health Hazard
10%
Iris
10%
Lens Implantation
10%
Vitrectomy
10%
Pharmacology, Toxicology and Pharmaceutical Science
Ivermectin
80%
Tolerability
80%
Onchocerciasis
51%
Infection
47%
Microfilaria (Nematode Larva)
42%
Mycobacterium chelonae
40%
Onchocerca volvulus
40%
Microfilaria
40%
Diethylcarbamazine
40%
Albendazole
40%
Besifloxacin
40%
Keratitis
17%
Adverse Event
15%
Amikacin
13%
Clarithromycin
8%
Clinical Trial
5%
Prevalence
5%
